Each dot is one of the 11 Drug Distribution stocks, sized by market cap. The median Revenue Growth (1y) (TTM) is 10.3% and the median P/E 23.68. Pinned to the edge: 1 outliers on X and 0 on Y.
Quadrants split at the medians. Hover a dot for its true values; click to open the company. Outliers are more than 3× the interquartile range beyond the quartiles.
| # | Industry | ||||
|---|---|---|---|---|---|
| 1 | MCKMckesson | 8.8% | 25.60 | $117.57B | Drug Distribution |
| 2 | CORCencora | 5.1% | 24.27 | $63.71B | Drug Distribution |
| 3 | CAHCardinal Health | 14.2% | 34.63 | $59.36B | Drug Distribution |
| 4 | BTSGBrightSpring Health Services | 26.4% | 32.84 | $12.02B | Home Health and Senior Care |
| 5 | HSICHenry Schein | 6.5% | 23.68 | $9.54B | Drug Distribution |
| 6 | AMRXAmneal Pharmaceuticals | 9.3% | 42.52 | $6.69B | Generic Drugs |
| 7 | AVAHAveanna Healthcare Holdings | 16.8% | 11.11 | $2.89B | Home Health and Senior Care |
| 8 | SBCSBC Medical Group Holdings | -6.8% | 13.61 | $546.74M | Healthcare Services |
| 9 | KMDAKamada | 13.2% | 20.64 | $455.98M | Biotechnology |
| 10 | GRDNGuardian Pharmacy Services | 10.3% | 0.07 | $4.93M | Drug Distribution |
| 11 | RHEPRegional Health Properties | 200.4%OUT | 0.93 | $4.12M | Home Health and Senior Care |
Among Drug Distribution stocks, the largest companies growing revenue faster than the median (10.3%) while trading below the median P/E (23.68) are Aveanna Healthcare Holdings (AVAH), Kamada (KMDA), Guardian Pharmacy Services (GRDN) and Regional Health Properties (RHEP). A low multiple next to fast growth can be an opportunity or a sign the market doubts the growth will last.
The largest companies with a P/E above the median and revenue growth below it are Mckesson (MCK), Cencora (COR), Henry Schein (HSIC) and Amneal Pharmaceuticals (AMRX).
The median P/E across the 11 Drug Distribution stocks plotted is 23.68, with the middle half between 12.36 and 29.22.
The median is 10.3%, with the middle half between 7.7% and 15.5%.
The rank correlation (Spearman) is -0.12, a weak negative relationship: companies with a higher Revenue Growth (1y) (TTM) tend to have a lower P/E.
A company whose value lies more than three interquartile ranges beyond the first or third quartile is treated as an outlier. By default it stays on the chart, pinned to the edge as an open marker, and its true value is shown in the tooltip and the table. In this view 1 companies are outliers on Revenue Growth (1y) (TTM) and 0 on P/E. You can switch to percentile clamping, exclude outliers, or plot raw values on a log scale.
Metrics from Business Quant's screener: trailing-twelve-month figures from SEC filings and multiples on the latest close. A company appears once even when it lists more than one share class. A company with a secondary business line in this industry is included unless you choose primary industry only. Nothing on this page is investment advice.